Glycerin-Preserved, Human-Donor, Corneoscleral Patch Grafts for Glaucoma Drainage Devices

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 22, 2017

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
GlaucomaGraft FailureIntraocular Pressure
Interventions
BIOLOGICAL

glaucoma drainage device implantation

Glaucoma drainage device implantation, a 350 mm2 Baerveldt (BG 101-350) GDD (Johnson and Johnson, Santa Ana, CA, USA) was performed using glycerin-preserved, human-donor, corneoscleral tissue ( the remaining from a heterologous, human-donor corneal button, obtained from the International Eye Bank of Thailand, after a clear corneal graft had been used for penetrating keratoplasty.) The tissue had been preserved in glycerin using the sterile technique and kept in a medical refrigerator for no longer than 6 months.

Trial Locations (1)

10700

Naris Kitnarong, Bangkoknoi

All Listed Sponsors
lead

Siriraj Hospital

OTHER

NCT04949347 - Glycerin-Preserved, Human-Donor, Corneoscleral Patch Grafts for Glaucoma Drainage Devices | Biotech Hunter | Biotech Hunter